Rolf Gedeborg, Hans Garmo , Camilla Thellenberg-Karlsson , Giuseppe Fallara , Johan Styrke, Ingela Franck Lissbrant and P€ar Stattin Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Translational Oncology and… Click to show full abstract
Rolf Gedeborg, Hans Garmo , Camilla Thellenberg-Karlsson , Giuseppe Fallara , Johan Styrke, Ingela Franck Lissbrant and P€ar Stattin Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Translational Oncology and Urology Research (TOUR), King’s College London, Guy’s Hospital, London, UK; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden; Division of Experimental Oncology, Unit of Urology URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden; Department of Oncology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
               
Click one of the above tabs to view related content.